Skip to main content
Signal8

Imagion Biosystems Limited (IBXXF)

Imagion Biosystems Limited is dedicated to advancing medical imaging through innovative technologies centered on superparamagnetic relaxometry. The company's core mission is to enable the early detection of diseases, with a particular focus on cancer, and to monitor the efficacy of therapeutic interventions. Its operational scope encompasses nanotechnology, biotechnology, and cancer diagnostics, all built upon its proprietary superparamagnetic relaxometry platform. Imagion's product pipeline includes MagSense, which is currently undergoing Phase I clinical trials for its application in HER2-positive breast cancer detection and management, as well as PrecisionMRX, an iron oxide nanoparticle engineered for general cancer detection. Imagion Biosystems also fosters strategic alliances, including a collaborative research program with Patrys Limited designed to integrate their respective technologies for improved imaging and diagnosis of brain tumors. Additionally, the company has a joint development agreement with Global Cancer Technology, Inc. to further develop GCT's novel nanoscintillator technology for the therapeutic treatment of breast cancer. The company was founded in 2016 and is headquartered in San Diego, California.

Sector: Medical - Diagnostics & Research

Industry: Medical - Diagnostics & Research

Imagion Biosystems Limited logo

Imagion Biosystems Limited

OTC:IBXXFHealthcare
CLOSED
Mkt Cap-
EV-
Float220.68M
O/S539.94M
VOL750 sh
$ Vol$3
Inst Own-
Net Cash/Sh-$0.00
Dilution
Financials Summary
Revenue$0
Net Income-$2.91M
Total Assets$1.38M
Free Cash Flow-$2.73M
Debt & Equity
Debt 637%
Total Debt$1.73M
Total Equity-$1.46M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
  1. 1:40Reverse split
    Nov 16, 202340 shares → 1
Balance Sheet Details
Assets$1.38M
Liabilities$2.84M
Accounts Receivable$23K
Accounts Payable$807K
Inventory$0
PP&E (Net)$6K
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Revenue$0$1.8M$3.36M$2.07M$1.93M$139K$278K$129K$14K$8$4K$4K
YoY Growth--46.4%61.9%7.5%1288.1%-49.9%114.6%852.5%167416.7%-99.8%-10.1%-
Cost of Revenue$6K$271K$3.55M$2.44M$1.83M$1.93M$1.53M$2.23M$0$15K$0$0
Gross Profit-$6K$1.53M-$189K-$368K$102K-$1.79M-$1.26M-$2.1M$14K-$15K$4K$4K
Gross Margin-85.0%-5.6%-17.7%5.3%-1290.6%-452.3%-1621.2%100.0%-180250.0%100.0%100.0%
Research and Development$1.42M$271K$3.55M$2.44M$1.83M$1.93M$1.53M$2.23M$1.46M$339K$2.62M$1.51M
Selling, General, and Administrative$176K$1.77M$6.95M$3.73M$2.54M$1.91M$1.23M$2.68M$1.84M$29K$166K$59K
Other$819K$0$0$1.66M$1.35M$1.29M$1.21M$1.28M$160K$0$0$0
Total Operating Expenses$2.42M$2.04M$10.5M$7.83M$5.72M$5.13M$3.97M$6.18M$4.86M$368K$2.79M$1.57M
Operating Income (EBIT)-$2.42M-$511K-$10.69M-$8.2M-$5.62M-$5.24M-$2.31M-$5.63M-$4.63M-$383K-$2.79M-$1.57M
Operating Margin--28.4%-318.1%-395.3%-291.2%-3771.7%-833.2%-4351.6%-34122.7%-4721416.7%-75100.0%-37960.0%
Interest Expense$572K$772K$762K$1K$3K$4K$6K$5K$632K$0$0$0
Interest Income$22K$7K$47K$20K$7K$0$15K$25K$55K$0$186K$132K
Other Income (Expense)-$517K-$885K$2.26M$1.58M$1.55M$1.62M$1.38M$417K-$632K-$316K-$186K-$132K
Income Before Tax (EBT)-$2.94M-$1.4M-$8.43M-$6.63M-$4.07M-$3.62M-$2.32M-$5.64M-$5.27M-$699K-$2.97M-$1.7M
Income Tax Expense-$27K$0$0$0$0$0$0$5K$0-$1$0$0
Net Income-$2.91M-$1.4M-$8.43M-$6.63M-$4.07M-$3.62M-$2.32M-$5.64M-$5.27M-$699K-$2.97M-$1.7M
Net Income Margin--77.6%-250.9%-319.4%-211.0%-2607.5%-835.5%-4359.7%-38775.3%-8620641.7%-80125.0%-41160.0%
Supplementary Data
EPS-0.02-0.05-0.41-0.35-0.23-0.29-0.61-0.04-0.04-0.01-214.69-122.69
Diluted EPS-0.02-0.05-0.41-0.35-0.24-0.29-0.61-0.04-0.04-0.01-214.68-122.68
Weighted Average OS277.47M44.94M30.48M28.03M26.19M18.68M8.98M234.27M183.55M102.64M20,49920,499
EBITDA-$2.42M-$240K-$6.96M-$5.77M-$3.79M-$3.31M-$2.21M-$5.49M-$4.49M-$527K-$2.68M-$1.53M
EBITDA Margin--13.3%-207.3%-277.9%-196.7%-2381.1%-796.5%-4239.9%-33093.7%-6496766.7%-72275.0%-37180.0%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Assets
Current Assets
Cash and Cash Equivalents$1.25M$1.8M$153K$3M$9.05M$8.92M$2.3M$2.95M$4.64M$8.05M$263K$110K
Short-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$1.25M$1.8M$153K$3M$9.05M$8.92M$2.3M$2.95M$4.64M$8.05M$263K$110K
Accounts Receivable$23K$599$50K$62K$21K$44K$48$335K$6K$0$0$0
Inventory$0$0$0$213K$118K$43K$66K-$240K$230K$0$0$0
Other Current Assets$4K$22K$107K-$122K-$3K-$17K-$17K$240K$32K$0$0$0
Total Current Assets$1.37M$1.88M$406K$3.37M$9.3M$9.08M$2.41M$3.32M$4.91M$8.06M$263K$110K
Long-Term Assets
Property, Plant & Equipment Net$6K$12K$2.69M$3.37M$234K$463K$878K$184K$251K$148K$270K$119K
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$0$0$0$0$0$0$0$0$0$0$0$0
Total Long-Term Assets$6K$12K$2.69M$3.37M$234K$463K$878K$184K$251K$148K$270K$119K
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$1.38M$1.89M$3.1M$6.74M$9.54M$9.54M$3.29M$3.5M$5.16M$8.2M$533K$229K
Liabilities
Current Liabilities
Accounts Payable$807K$1.4M$1.07M$220K$289K$195K$479K$665K$271K$305K$107K$82K
Short-Term Debt$1.71M$1.89M$1.15M$0$0$0$0$0$0$9.41M$4.1M$766K
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$0$0$0$188K$0$0-$9.47M$0$0
Other Current Liabilities$301K$112K$328K$130K$130K$98K-$46K$138K$110K$338K$0$0
Total Current Liabilities$2.84M$3.44M$3.46M$1.17M$524K$609K$867K$878K$432K$305K$4.2M$848K
Long-Term Liabilities
Long-Term Debt$0$0$507K$0$0$0$0$0$0$0$2.32M$2.06M
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$2K$1K$2K$1K$0$0$0$0$0$0
Total Long-Term Liabilities$0$0$2.19M$2.41M$23K$206K$416K$12K$33K$305K$2.32M$2.06M
Other Liabilities$0$0$0$0$0$0$0$0$0-$305K$0$0
Total Liabilities$2.84M$3.44M$5.66M$3.58M$547K$814K$1.28M$891K$465K$305K$6.52M$2.91M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$0
Common Stock$44.55M$42.26M$40.27M$38.4M$38.4M$34.68M$24.94M$22.42M$19.38M$20.34M$56K$50K
Retained Earnings-$48.17M-$45.28M-$46.16M-$37.73M-$31.1M-$27.03M-$23.41M-$21.09M-$15.45M-$12.75M-$6.04M-$2.73M
Comprehensive Income & Other$2.16M$1.48M$3.33M$2.49M$1.7M$1.08M$483K$1.28M$769K$306K$0$0
Other Stockholders' Equity$2.16M$1.48M$3.33M$2.49M$1.7M$1.08M$483K$1.28M$769K$306K$0$0
Total Equity-$1.46M-$1.54M-$2.56M$3.16M$8.99M$8.73M$2.01M$2.61M$4.7M$7.9M-$5.99M-$2.68M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$1.38M$1.89M$3.1M$6.74M$9.54M$9.54M$3.29M$3.5M$5.16M$8.2M$533K$229K
Supplementary Data
Total Debt$1.73M$1.92M$4.08M$3.11M$31K$447K$592K$37K$54K$9.41M$6.41M$2.83M
Net Debt$484K$119K$3.93M$107K-$9.02M-$8.47M-$1.71M-$2.91M-$4.59M$1.36M$6.15M$2.72M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Operating Activities
Net Income-$2.91M-$1.4M-$8.43M-$6.63M-$4.07M-$3.62M-$2.32M-$5.64M-$5.27M-$699K-$2.97M-$1.7M
Depreciation & Amortization$6K$265K$799K$742K$273K$244K$96K$144K$140K$15K$105K$32K
Deferred Income Tax$0$0$0-$6.3M-$850K-$944K$346K$0$0$0$0$0
Stock-Based Compensation$0$8K$313K$441K$336K$286K-$715K$566K$422K$0$0$0
Changes in Working Capital:
  Accounts Receivable-$10K$49K$250K-$134K-$23K-$45K$16K-$30K-$45K$0$0$0
  Inventory$0$0$0$0$0$0$0$0$0$0$0$0
  Accounts Payable-$490K$0$1.2M$114K$56K-$126K-$202K$251K-$246K$217K$0$0
  Other Working Capital$0$0$0$0$0$0-$30K$194K-$224K$29K-$47K-$16K
Total Working Capital Change-$500K$49K$1.45M-$20K$32K-$170K-$216K$415K-$515K$211K-$47K-$16K
Other Non-Cash Items$674K$216K$243K$6.31M$854K$1.08M-$18K$5.5M$5.13M$105K$62K$40K
Net Cash from Operating-$2.73M-$859K-$5.62M-$5.46M-$3.42M-$3.12M-$2.83M-$5.5M-$4.71M-$181K-$2.85M-$1.64M
Investing Activities
Capital Expenditures$0$57K-$129K-$343K-$148K-$5K-$8K-$56K-$250K$0-$241K-$30K
Acquisitions$0$0$0$0$0$0$0$0$0$0$0$0
Purchases of Investments$0$0$0$0$0$0$0$0$0$0$0$0
Sales of Investments$0$0$0$0$0$0$0$0$0$0$0$0
Other Investing Activities$0$0$0$26K-$62K$0$0$0$0$0$0$0
Net Cash from Investing$0$57K-$129K-$317K-$210K-$5K-$8K-$56K-$250K$0-$241K-$30K
Financing Activities
Debt Repaid--$457K-$2.36M$652K$243K-$158K-$57K--$77K---$826K
Common Stock Issuance$2.19M$2.11M$1.61M$2K$3.72M$10.88M$2.28M$2.9M$12.3M$0$0$0
Common Stock Repurchases$0$0$0$0-$4K-$905K-$9K-$37K-$750K$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$0-$130K-$1.08M$0$0-$325K-$81K-$87K-$67K$156K$3.23M$643K
Net Cash from Financing$2.19M$2.44M$2.9M-$650K$3.48M$9.81M$2.25M$2.77M$9.58M$156K$3.23M$1.47M
Forex Effect$117K$14K-$3K$377K$288K-$61K-$65K$28K$5K-$135K$0$0
Net Change in Cash-$424K$1.65M-$2.85M-$6.05M$131K$6.62M-$652K-$1.69M$4.63M-$244K$153K-$203K
Supplementary Data
Operating Cash Flow-$2.73M-$859K-$5.62M-$5.88M-$3.42M-$3.12M-$2.83M-$5.5M-$4.71M-$181K-$2.85M-$1.64M
Capital Expenditure$3$0-$129K-$343K-$148K-$5K-$8K-$56K-$250K$0-$241K-$30K
Free Cash Flow-$2.73M-$859K-$5.75M-$6.22M-$3.57M-$3.13M-$2.83M-$5.55M-$4.96M-$181K-$3.1M-$1.67M
Cash at Beginning$1.67M$153K$3M$9.05M$8.92M$2.3M$2.95M$4.64M$19K$263K$110K$313K
Cash at End$1.25M$1.8M$153K$3M$9.05M$8.92M$2.3M$2.95M$4.64M$19K$263K$110K